Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

23847studies shown

Showing 9,565-9,576 of 23,847

Drug study icon

CompletedEUCTR 2012-004509-29

Antidepressant treatments during pregnancy and lactation: prediction of drug exposure through breastfeeding and evaluation of drug effect on the neonatal adaptation and the development of the youn...

This study is completed in France. It focuses on Depression.

In France

DepressionOther

Countries: France
Sponsor: Hospices Civils de Lyon
Condition: Depression

Drug study icon

OngoingEUCTR 2009-016463-10

Antidepressive response to add-on occupational therapy in people with major depression: A controlled multicentre study

This study is ongoing in Germany. It focuses on depression.

In Germany

DepressionOther

Countries: Germany
Sponsor: LWL University Hospital Bochum
Condition: Depression

Drug study icon

CompletedEUCTR 2009-015165-31

Antiglucocorticoid augmentation of antiDepressants in Depression: a study

This study is completed in the United Kingdom. It is testing antiglucocorticoid augmentation of antiDepressants for depression.

In United Kingdom

DepressionOther

Countries: United Kingdom
Sponsor: Northumberland, Tyne and Wear NHS Foundation Trust
Condition: Depression

Drug study icon

CompletedNCT00585702

Antimanic Drug Use in Pregnancy

This summary needs review. Please check the official study record and contact the research team for details.

In Pittsburgh

BipolarityOtherFrom 18 Years to 45 Years

Countries: United States
Sponsor: University of Pittsburgh
Condition: Bipolarity

Behavioral study icon

CompletedNCT04481048

Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1

This summary needs review. Please check the official study record and contact the research team for details.

In Cincinnati

ADHDBehavioralFrom 8 Years to 16 Years

Countries: United States
Sponsor: Children's Hospital Medical Center, Cincinnati
Condition: ADHD

Drug study icon

CompletedNCT01636037

Antipsychotic Augmentation With L-Dopa

This summary needs review. Please check the official study record and contact the research team for details.

In Toronto

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: Canada
Sponsor: Centre for Addiction and Mental Health
Condition: Schizophrenia

Drug study icon

CompletedNCT00417482

Antipsychotic Discontinuation in Alzheimer's Disease

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Tuscaloosa

SchizophreniaDrugFrom 50 Years to 95 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Schizophrenia

Drug study icon

WithdrawnNCT01758887

Antipsychotic Discontinuation in High-risk Subjects

This summary needs review. Please check the official study record and contact the research team for details.

In Seoul

SchizophreniaOtherFrom 16 Years to 40 Years

Countries: South Korea
Sponsor: Seoul National University Hospital
Condition: Schizophrenia

Drug study icon

TerminatedNCT01621737

Antipsychotic Effects of Oxytocin

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Irvine

SchizophreniaDrugOver 21 Years

Countries: United States
Sponsor: University of California, San Diego
Condition: Schizophrenia

Drug study icon

TerminatedNCT01913327

Antipsychotic Effects on Brain Function in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In San Francisco

SchizophreniaDrugFrom 18 Years to 40 Years

Countries: United States
Sponsor: University of California, San Francisco
Condition: Schizophrenia

Drug study icon

CompletedNCT06040944

Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients

This study exists to see whether smoking support or smoking-related treatment can make care clearer and more responsive. Researchers are trying to understand whether smoking support or smoking-related treatment can better support energy, concentration, and everyday functioning.

In Giza

SchizophreniaDrugOver 20 Years

Countries: Egypt
Sponsor: Fayoum University
Condition: Schizophrenia

Drug study icon

TerminatedNCT02435095

Antipsychotic Induced Structural and Functional Brain Changes

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Aachen

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: Germany
Sponsor: RWTH Aachen University
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.